P2.01-06 NAUTIKA1 Study: Preliminary Efficacy and Safety Data with Neoadjuvant Alectinib in Patients with Stage IB-III ALK+ NSCLC

J.M. Lee, Eric M. Toloza, Harvey I. Pass, Bruce E. Johnson, John V. Heymach, Lynette M. Sholl, Anjali Saqi, William D. Travis, Ignacio I. Wistuba, Jules Lin, Mark G. Kris, Alexander I. Spira, Catherine A. Shu, Andreas Saltos, B. Ding, Katja Schulze, Q. Zhu, C. Ngiam, Ilze Bāra, Jamie E. Chaft